Insiders who reported open-market trades in the last 12 months at the companies J. Robert Kerrey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Saumya Sutaria - $27.64M in THC purchases and sales in the last 12 months
Lisa Y. Foo - $8.97M in THC purchases and sales in the last 12 months
Thomas W. Arnst - $7.53M in THC purchases and sales in the last 12 months
Tammy Romo - $7.52M in THC purchases and sales in the last 12 months
R. Scott Ramsey - $4.60M in THC purchases and sales in the last 12 months
Paola M. Arbour - $4.20M in THC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
J. Robert Kerrey is a corporate insider, tracked as Director of TENET HEALTHCARE CORP (THC). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has J. Robert Kerrey submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has J. Robert Kerrey been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($5.10M) across all tracked filings.
J. Robert Kerrey is Director of TENET HEALTHCARE CORP (THC). 8 SEC Form 4 filings on record going back to 2025, most recently on 17 September 2026. Most recent open-market trade: sold $662K of THC on 17 September 2026. Lifetime open-market sales: $5.10M.
Recent transactions
16
The latest 16 SEC Form 4 transactions reported by J. Robert Kerrey.
InsiderAlpha's records for J. Robert Kerrey go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
